22 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:29am
at pharmaceu�cal companies has tradi�onally been led by a process of laboratory science, with highly skilled chemists and technicians physically isola�ng
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
prioritizes attracting and developing highly skilled talent and invests in creating a diverse, equitable and inclusive workplace that supports employees
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
and developing highly skilled talent and invests in creating a diverse, equitable and inclusive workplace that supports employees’ flexible ways
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
P E O P L E Attract and develop highly skilled talent and invest in creating a diverse, equitable and inclusive workplace that supports our staff’s
6-K
EX-99.1
nbb8w0cu
29 Jun 21
Current report (foreign)
7:38am
6-K
EX-99.1
f6gvd v6979c
17 Dec 20
Current report (foreign)
6:01am
6-K
EX-99.1
r21qu8tid9ejkw9lj4t
10 Jan 20
Better Health, Brighter Future 2019 SUSTAINABLE VALUE REPORT Takeda Pharmaceutical Company Limited
6:36am
424B3
2s059crc0p yuioe40
14 Nov 19
Prospectus supplement
6:10am
F-4/A
7qad51dck809w
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
kuqo1 5ozdocr
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
o42ttvb
27 Jun 19
Annual report (foreign)
6:41am
20FR12B/A
EX-10.1
kuht52hh8m isaba
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B/A
nnpwumxfdea mdwc
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
9a4 iy4hut4s9v
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
20FR12B
EX-10.1
c54kj 3m30ax8je1
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am